Investigation of EGFR-targeted gelatin nanoparticles incorporated with cisplatin for lung cancer therapy via aerosol delivery
博士 === 國立臺灣大學 === 醫學工程學研究所 === 96 === Lung cancer is one of the most harmful forms of cancer. The long-term survival rate of lung cancer patients treated by conventional modalities remains far from satisfactory. Encapsulated anticancer drugs in nanocariers, can protect not only the integrity of drug...
Main Authors: | Ching-Li Tseng, 曾靖孋 |
---|---|
Other Authors: | 林峰輝 |
Format: | Others |
Language: | en_US |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/93793721373402975273 |
Similar Items
-
Monoclonal Antibody Ligand Mediated Gelatin Nanoparticles Targeting to EGFR for Lung Cancer Therapy
by: Wen-Chun Lin, et al.
Published: (2010) -
The Synergistic Anticancer Effect of Dual Drug- (Cisplatin/Epigallocatechin Gallate) Loaded Gelatin Nanoparticles for Lung Cancer Treatment
by: Yin-Ju Chen, et al.
Published: (2020-01-01) -
A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin
by: Gunji, Shutaro
Published: (2014) -
Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism
by: Iwona Karwaciak, et al.
Published: (2021-05-01) -
Multimodal therapeutic strategy for pancreatic cancer: EGFR-targeted gelatin-based nanoparticles for combination wild-type p53 gene and cytotoxic drug delivery.
Published: ()